XML 71 R44.htm IDEA: XBRL DOCUMENT v3.25.0.1
Business Segments and Geographic Information (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Information on Company's Business Segments
Financial information for the Company’s reportable business segments is presented below.
For the Year Ended December 31, 2024
FMTHSTFSDPTotal SegmentsEliminationsIDEX
NET SALES
External customers$1,231.8 $1,294.0 $743.0 $3,268.8 $— $3,268.8 
Intersegment sales1.4 4.1 1.3 6.8 (6.8)— 
 Net sales1,233.2 1,298.1 744.3 3,275.6 (6.8)3,268.8 
Adjusted segment cost of sales(1)
(639.4)(769.5)(411.9)(1,820.8)6.8 (1,814.0)
Other segment expenses(2)
(187.5)(181.8)(118.2)(487.5)
Segment Adjusted EBITDA406.3 346.8 214.2 967.3 
For the Year Ended December 31, 2023
FMTHSTFSDPTotal SegmentsEliminationsIDEX
NET SALES
External customers$1,244.2 $1,313.5 $716.2 $3,273.9 $— $3,273.9 
Intersegment sales2.9 2.9 2.6 8.4 (8.4)— 
 Net sales1,247.1 1,316.4 718.8 3,282.3 (8.4)3,273.9 
Adjusted segment cost of sales(1)
(650.1)(783.1)(400.6)(1,833.8)8.4 (1,825.4)
Other segment expenses(2)
(180.9)(173.8)(109.6)(464.3)
Segment Adjusted EBITDA416.1 359.5 208.6 984.2 

For the Year Ended December 31, 2022
FMTHSTFSDPTotal SegmentsEliminationsIDEX
NET SALES
External customers$1,166.2 $1,336.8 $678.9 $3,181.9 $— $3,181.9 
Intersegment sales1.1 2.4 0.3 3.8 (3.8)— 
 Net sales1,167.3 1,339.2 679.2 3,185.7 (3.8)3,181.9 
Adjusted segment cost of sales(1)
(623.3)(738.9)(388.1)(1,750.3)3.8 (1,746.5)
Other segment expenses(2)
(169.8)(188.5)(107.2)(465.5)
Segment Adjusted EBITDA374.2 411.8 183.9 969.9 

(1) Adjusted segment cost of sales represents Cost of sales excluding fair value inventory step-up charges.
(2) Other segment expenses consists primarily of selling, general and administrative expenses.

202420232022
ADJUSTED EBITDA
Fluid & Metering Technologies $406.3 $416.1 $374.2 
Health & Science Technologies 346.8 359.5 411.8 
Fire & Safety/Diversified Products214.2 208.6 183.9 
Segment Adjusted EBITDA967.3 984.2 969.9 
Corporate and other(1)
(93.0)(84.6)(85.7)
Interest expense - net(44.5)(51.7)(40.7)
Depreciation(68.5)(57.2)(50.7)
Amortization of intangible assets(107.1)(94.9)(69.0)
Fair value inventory step-up charges(9.6)(1.6)(8.5)
Restructuring expenses and asset impairments(9.3)(10.9)(4.5)
Net impact from the exit of a COVID-19 testing application(2)
— — 1.1 
Gain on sale of businesses - net4.0 84.7 34.8 
Gains on sales of assets— — 2.7 
Credit loss on note receivable from collaborative partner(3)
— (7.7)— 
Income before income taxes$639.3 $760.3 $749.4 

(1) Corporate expenses that can be identified with a segment have been included in determining segment results. The remainder is included in Corporate and other.
(2) Represents the acceleration of previously deferred revenue of $17.9 million, net of an impairment charge of $16.8 million as a result of a customer’s decision to discontinue further investment in commercializing its COVID-19 testing application in the HST segment in 2022 that did not reoccur in 2023 or 2024. See Note 14, “Restructuring Expenses and Asset Impairments,” for further detail.
(3) Represents a reserve recorded on an investment with a collaborative partner in Other (income) expense – net during 2023. During the fourth quarter of 2023, the Company converted the promissory note receivable from the collaborative partner to equity, resulting in a cost method investment with zero value. See Note 3, “Collaborative Investments,” for further detail.
202420232022
DEPRECIATION
Fluid & Metering Technologies$17.3 $14.1 $16.1 
Health & Science Technologies41.2 33.2 25.7 
Fire & Safety/Diversified Products9.0 8.9 8.4 
Total Segments67.5 56.2 50.2 
Corporate and other1.0 1.0 0.5 
Total depreciation$68.5 $57.2 $50.7 
AMORTIZATION OF INTANGIBLE ASSETS
Fluid & Metering Technologies$21.1 $22.7 $20.8 
Health & Science Technologies79.7 65.8 41.6 
Fire & Safety/Diversified Products6.3 6.4 6.6 
Total amortization$107.1 $94.9 $69.0 
CAPITAL EXPENDITURES
Fluid & Metering Technologies$14.8 $24.2 $25.3 
Health & Science Technologies40.1 55.1 32.0 
Fire & Safety/Diversified Products10.2 9.7 10.5 
Total Segments65.1 89.0 67.8 
Corporate and other— 0.9 0.2 
Total capital expenditures$65.1 $89.9 $68.0 

December 31, 2024December 31, 2023
ASSETS
Fluid & Metering Technologies$1,609.4 $1,674.7 
Health & Science Technologies4,142.6 3,262.4 
Fire & Safety/Diversified Products794.1 792.6 
Total Segments6,546.1 5,729.7 
Corporate and other199.2 135.5 
Total assets$6,745.3 $5,865.2 
Schedule of Sales From External Customers and Long-Lived Assets
Information about the Company’s long-lived assets in different geographical regions as of December 31, 2024 and 2023 is shown below.
December 31, 2024December 31, 2023
LONG-LIVED ASSETS — PROPERTY, PLANT AND EQUIPMENT
U.S.$271.7 $219.2 
North America, excluding U.S.20.6 24.0 
Netherlands
51.4 61.5 
Europe, excluding Netherlands
71.6 76.9 
Asia44.7 48.3 
Other(1)
0.4 0.4 
Total long-lived assets - net$460.4 $430.3 

(1) Other includes: South America, Middle East, Australia and Africa.